Publications

Urban JD, Haws LC, Staskal DF, Scott LF, Scott PS, Tachovsky AT, Unice KM, Harris MA. A framework for evaluating serum dioxin data derived from biomonitoring studies. Presented at Dioxin 2008, Birmingham, England, August 17-22 2008.

Staskal DF, Scott LLF, Haws LC, Luksemburg WJ, Birnbaum LS, Nguyen LM, Urban JD, Williams ES, Paustenbach DJ, Harris MA. 2008. Assessment of polybrominated diphenyl ether exposures and health risks associated with consumption of southern Mississippi catfish. Environ Sci Technol 42(17):6755-6761; doi: 10.1021/es800613k.

Subramaniam RP, Chen C, Crump KS, Devoney D, Fox JF, Portier CJ, Schlosser PM, Thompson CM, White P. 2008. Uncertainties in biologically-based modeling of formaldehyde-induced respiratory cancer risk: Identification of key issues. Risk Analysis 28(4):907–923; doi: 10.1111/j.1539-6924.2008.01083.x.

Thompson CM, Subramaniam RP, Grafström RC. 2008. Mechanistic and dose considerations for supporting adverse pulmonary physiology in response to formaldehyde. Toxicol Appl Pharmacol 233(3):355–359.

Williams CW, Perry CS. Risk assessment for arsenic on indoor surfaces. Presented at the Society for Risk Analysis Annual Meeting, Boston, MA, December 2008.

Thompson CM, Sonawane B, Barton HA, DeWoskin RS, Schlosser P, Lipscomb JC, Chiu W, Krishnan K. 2008. Approaches for applications of physiologically based pharmacokinetic models in risk assessment. J Toxicol Environ Health B 11(7):519–547; doi: 10.1080/10937400701724337.

Robison TW. Case examples of qualification of extractables and leachables in therapeutic biologic products: A toxicological perspective. WCBP CMC Strategy Forum–Extractables and Leachables: Challenges and Strategies in Biopharmaceutical Development (Sponsored by CASSS and the United States Food and Drug Administration), Washington, DC, January 2008.

DeSesso JM, Watson RE, Keen CL, Hazelden KP, Haws LC, Li AA. 2008. Analysis and integration of developmental neurotoxicity and ancillary data into risk assessment: A case study of dimethoate. J Toxicol Environ Health A 72(2):94-109; doi: 10.1080/15287390802477452.

Wheeler MW, Fadel W, Robertson J, John Bailer A. 2007. Confidence interval construction for relative toxicity endpoints such as LD₅₀ or LD₉₀ ratios. J Econ Entomol 100(6):1945-9; doi: 10.1093/jee/100.6.1945. PMID: 18232415.

Britt JK, James RC. 2007. Toxicology. In: Kirk-Othmer Encyclopedia of Chemical Technology. John Wiley & Sons, Inc., Hoboken, NJ. pp. 201-252.

Ferriby LL, Knutsen JS, Harris MA, Unice KM, Scott P, Nony P, Haws LC, and Paustenbach D. 2007. Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States Population. J Exp Sci Environ Epidemiol 17:358-371.

Staskal DF, Birnbaum LS. 2007. Brominated flame retardants. In: Maxcy-Rosenau-Last Public Health and Preventive Medicine, 15th edition.

DeSesso J, Watson RE, Keen CL, Hazleden KP, Haws LC, Li AA. Integration of developmental toxicity data into risk assessment: A case study of dimethoate. Society of Toxicology 46th Annual Meeting, Charlotte, NC, March 2007.

Proctor DM, Gatto NM, Hong SJ, Allamneni KP. 2007. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment. Toxicol Sci 98(2):313–326; doi: 10.1093/toxsci/kfm075.

Diliberto JJ, Staskal DF, Hakk H, Birnbaum LS. Differential urinary protein binding of PBDEs in mice. Society of Toxicology 46th Annual Meeting, Charlotte, NC, March 2007.

Mowat F, Shum M, Kelsh MA. 2007. Exposure assessment in epidemiology. In: Boslaugh S (ed.), Encyclopedia of

Epidemiology. Sage Publications.

Morimoto L, Kelsh MA. 2007. Biomarkers. In: Boslaugh S (ed.), Encyclopedia of Epidemiology. Sage Publications.

Kelsh MA, Alexander DD. 2007. Occupational and environmental epidemiology. In: Boslaugh S (ed.), Encyclopedia of Epidemiology. Sage Publications.

Kelsh MA. 2007. Injury epidemiology. In: Boslaugh S (ed.), Encyclopedia of Epidemiology. Sage Publications.

Robison TW. Toxicology in the nonclinical development of drugs and biologics. Pharmaceutical Education and Research Institute, Genetic Toxicology, Arlington, VA, September 2007.